Interleukin-31 (IL-31) protein structure, as predicted by alphafold. Believed to play a role in atopic dermatitis. Lokivetmab is a monoclonal antibody drug that targets IL-31 and is used to treat atopic dermatitis in dogs. 3D rendering: Molecular surface rendering of the molecule (in white and blue), with part of the surface cut away, revealing a cartoon model of the protein (in white and gold).
| px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TPG34403839
Source:
達志影像
Authorization Type:
RF
Release Information:
須由TPG 完整授權
Model Release:
Not Available
Property Release:
N/A
Right to Privacy:
No
Same folder images:
interleukinIL-31IL31cytokineinflammatoryinflammationdiseaseatopicdermatitisoncostatinmonocyteepithelialcellskinimmunitypathogeneczemaitchpruritislokivetmabstructurepeptideproteinaminoacidmoleculepolypeptidepolymeratomsdiseasehealthmolecularmodel3Drendering3Dillustrationartworkillustrationcgidigitallygeneratednobodyno-onebiochemistrybiochemical3dthreedimensional
3D3D3dIL-31IL31acidaminoartworkatomsatopicbiochemicalbiochemistrycellcgicytokinedermatitisdigitallydimensionaldiseasediseaseeczemaepithelialgeneratedhealthillustrationillustrationimmunityinflammationinflammatoryinterleukinitchlokivetmabmodelmolecularmoleculemonocyteno-onenobodyoncostatinpathogenpeptidepolymerpolypeptideproteinpruritisrenderingskinstructurethree
Loading